DynamicDTA: Drug-Target Binding Affinity Prediction Using Dynamic Descriptors and Graph Representation
Predicting drug-target binding affinity (DTA) is essential for identifying potential therapeutic candidates in drug discovery. However, most existing models rely heavily on static protein structures, often overlooking the dynamic nature of proteins, which is crucial for capturing conformational flexibility that will be beneficial for protein binding interactions. We introduce DynamicDTA, an innovative deep learning framework that incorporates static and dynamic protein features to enhance DTA prediction. The proposed DynamicDTA takes three types of inputs, including drug sequence, protein sequence, and dynamic descriptors. A molecular graph representation of the drug sequence is generated and subsequently processed through graph convolutional network, while the protein sequence is encoded using dilated convolutions. Dynamic descriptors, such as root mean square fluctuation, are processed through a multi-layer perceptron. These embedding features are fused with static protein features using cross-attention, and a tensor fusion network integrates all three modalities for DTA prediction. Extensive experiments on three datasets demonstrate that DynamicDTA achieves by at least 3.4% improvement in RMSE score with comparison to seven state-of-the-art baseline methods. Additionally, predicting novel drugs for Human Immunodeficiency Virus Type 1 and visualizing the docking complexes further demonstrates the reliability and biological relevance of DynamicDTA.
Code (1)
Tasks
Drug DiscoverySimilar Papers 제목 키워드 기반
DeepDTA: Deep Drug-Target Binding Affinity Prediction
The identification of novel drug-target (DT) interactions is a substantial part of the drug discovery process. Most of the computational methods that have been proposed to predict DT interactions have focused on binary c…
Binary ClassificationDrug DiscoveryPredictionGraphDTA: prediction of drug–target binding affinity using graph convolutional networks
While the development of new drugs is costly, time consuming, and often accompanied with safety issues, drug repurposing, where old drugs with established safety are used for medical conditions other than originally deve…
Deep LearningDrug DiscoveryRecommendation SystemsResDTA: Predicting Drug-Target Binding Affinity Using Residual Skip Connections
The discovery of novel drug target (DT) interactions is an important step in the drug development process. The majority of computer techniques for predicting DT interactions have focused on binary classification, with th…
Binary ClassificationDeep LearningHierarchical Graph Representation Learning for the Prediction of Drug-Target Binding Affinity
The identification of drug-target binding affinity (DTA) has attracted increasing attention in the drug discovery process due to the more specific interpretation than binary interaction prediction. Recently, numerous dee…
Drug DiscoveryGraph LearningGraph Representation LearningRepresentation LearningDrug-target affinity prediction method based on consistent expression of heterogeneous data
The first step in drug discovery is finding drug molecule moieties with medicinal activity against specific targets. Therefore, it is crucial to investigate the interaction between drug-target proteins and small chemical…
Drug Discovery